Gene Sciences Financing
Gene Sciences, Inc., Corporation just released form D for $12.00 million equity financing. This is a new filing. Gene Sciences was able to fundraise $8.00 million so far. That is 66.67% of the fundraising offer. The total offering amount was $12.00 million. The form was filed on 2016-11-21. The reason for the financing was: Includes $45.00 of Common Stock sold separately from Series A Preferred Stock to one purchaser included below.. The fundraising still has about $4.00 million more and is not closed yet. We have to wait more to see if the offering will be fully taken.
Gene Sciences is based in California. The filler’s business is Other Health Care. The form was filed by LYNNE ROLLINS SECRETARY, TREASURER AND CFO. The company was incorporated in 2016. The filler’s address is: 12481 High Bluff Drive, Suite 150, San Diego, Ca, California, 92130. James C. Blair is the related person in the form and it has address: 12481 High Bluff Drive, Suite 150, San Diego, Ca, California, 92130. Link to Gene Sciences Filing: 000138296316000260.
Analysis of Gene Sciences Offering
On average, startups in the Other Health Care sector, sell 68.60% of the total offering size. Gene Sciences sold 66.67% of the offering. The financing is still open. The average fundraising amount for companies in the Other Health Care industry is $1.16 million. The total amount raised is 589.66% bigger than the average for companies in the Other Health Care sector. The minimum investment for this financing was set at $0. If you know more about the reasons for the financing, please comment below.
What is Form D? What It Is Used For
Form D disclosures could be used to track and understand better your competitors. The information in Form D is usually highly confidential for ventures and startups and they don’t like revealing it. This is because it reveals amount raised or planned to be raised as well as reasons for the financing. This could help competitors. Entrepreneurs usually want to keep their financing a ‘secret’ so they can stay in stealth mode for longer.
Why Fundraising Reporting Is Good For Gene Sciences Also
The Form D signed by LYNNE ROLLINS might help Gene Sciences, Inc.’s sector. First, it helps potential customers feel more safe to deal with a firm that is well financed. The odds are higher that it will stay in the business. Second, this could attract other investors such as venture-capital firms, funds and angels. Third, positive PR effects could even bring leasing firms and venture lenders.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.